Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Fund and Insider Trading News: Bill Ackman, Anthony Scaramucci, Crispin Odey, Toscafund Asset Management, Incyte Corporation (INCY), Intellicheck Inc (IDN), and More

Baxon Capital Announces First Southwest Florida-Focused Opportunity Zone Fund (
FORT MYERS, Fla., July 8, 2020 /PRNewswire/ — Baxon Capital, LLC (“Baxon”) announced today an initiative to launch the first investment fund dedicated exclusively to Opportunity Zone investments in southwest Florida. The fund will leverage the expertise of the Baxon team in focusing on investments into real estate and local businesses located in lower income areas in the region. With the establishment of its Opportunity Zone fund, Baxon aims to contribute to the region through investments that positively impact local communities while providing favorable investor returns. The fund will utilize the Federal Opportunity Zone program which was created in 2017 with the goal of attracting private investment to support development in lower income areas by providing significant tax incentives to investors.

Preqin Quarterly Update: Real Estate, Q2 2020 (
Activity in the private real estate market declined significantly in the second quarter of 2020. The economic uncertainty caused by the COVID-19 pandemic and ongoing restrictions led to a drop in PERE deal volume from $78bn in Q1 2020 to just $30bn in Q2. Read our latest real estate industry update for a detailed look at fundraising, funds in market, investors, deals, and performance over the past quarter. The report also features exclusive comment on how the pandemic is accelerating trends and creating new dynamics within property sectors from Laura Dietzel, Partner and Senior Real Estate Analyst at audit, tax, and consulting firm RSM.

Yext Inc (YEXT) CEO Howard Lerman Sold $1.3 million of Shares (Guru Focus)
CEO of Yext Inc, Howard Lerman, sold 75,000 shares of YEXT on 07/06/2020 at an average price of $17.36 a share. The total sale was $1.3 million. Yext Inc provides a knowledge engine platform that lets businesses manage their digital knowledge in the cloud and sync it to over 100 services including Apple Maps, Bing, Cortana, Facebook, Google, Google Maps, Instagram, Siri and Yelp.

Wednesday 7/8 Insider Buying Report: CULP, CZNC (
On Tuesday, Culp’s Director, Kenneth W. McAllister, made a $20,500 purchase of CULP, buying 2,000 shares at a cost of $10.25 a piece. Culp is trading up about 2.3% on the day Wednesday. Before this latest buy, McAllister purchased CULP on 2 other occasions during the past twelve months, for a total investment of $38,670 at an average of $12.89 per share. And at Citizens & Northern, there was insider buying on Tuesday, by Director Frank G. Pellegrino who purchased 397 shares at a cost of $19.02 each, for a trade totaling $7,552. Before this latest buy, Pellegrino bought CZNC at 11 other times during the past year, for a total cost of $46,757 at an average of $23.47 per share. Citizens & Northern is trading off about 0.1% on the day Wednesday.

The CFO, COO, Secretary & Treas of Intellicheck Mobilisia (NASDAQ: IDN) is Buying Shares (Analyst Ratings)
Today, the CFO, COO, Secretary & Treas of Intellicheck Mobilisia (IDN), Billy Joe White, bought shares of IDN for $244K. This recent transaction increases Billy Joe White’s holding in the company by 664.82% to a total of $1.93 million. In addition to Billy Joe White, 2 other IDN executives reported Buy trades in the last month.

Incyte Corp (INCY) EVP & Chief Medical Officer Steven H Stein Sold $3.9 million of Shares (Guru Focus)
EVP & Chief Medical Officer of Incyte Corp, Steven H Stein, sold 36,124 shares of INCY on 07/06/2020 at an average price of $107.25 a share. The total sale was $3.9 million. Incyte Corp is a biopharmaceutical company. It discovers, develops and commercializes proprietary therapeutics. Its product JAKAFI, a JAK1 and JAK2 inhibitor is used for treatment of patients with intermediate or high risk myelofibrosis. Incyte Corp has a market cap of $23.62 billion; its shares were traded at around $108.64 with and P/S ratio of 10.60.